IDiyas

For the Inventor, By the Inventor

The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Patent No.:

US 10864216 B1

PDFFull Text
Date of Patent:
Dec. 15, 2020

Filed:

Mar. 05, 2018

Phenothiazine diaminium salts and their use

Applicant:

Wista Laboratories Ltd., Singapore, SG;

Inventors:

Colin Marshall, Aberdeenshire, GB;

Scott Clunas, Aberdeenshire, GB;

John Mervyn David Storey, Aberdeenshire, GB;

James Peter Sinclair, Aberdeenshire, GB;

Thomas Craven Baddeley, Aberdeenshire, GB;

Ahtsham Ishaq, Aberdeenshire, GB;

Michael Simpson, Aberdeenshire, GB;

Craig Williamson, Guildford, GB;

Barry Alan Wood, Aberdeenshire, GB;

Claude Michel Wischik, Aberdeenshire, GB;

Charles Robert Harrington, Aberdeenshire, GB;

Janet Elizabeth Rickard, Aberdeenshire, GB;

David Horsley, Aberdeenshire, GB;

Yin Sze Loh, Singapore, SG;

Karrar Ahmad Khan, West Bridgeford, GB;

Christopher Paul Larch, Aberdeenshire, GB;

Assignee:

WisTa Laboratories, Ltd., Singapore, SG;

Attorney:

Wolf, Greenfield & Sacks, P.C.

Primary Examiner:

Bethany P Barham

Assistant Examiner:

Barbara S Frazier

Int. Cl.
CPC ...
A61K 31/5415 (2006.01); A61P 35/00 (2006.01); A61P 31/12 (2006.01); A61P 31/14 (2006.01); A61P 31/18 (2006.01); A61P 31/04 (2006.01); A61P 33/02 (2006.01); A61P 33/06 (2006.01); A61K 9/00 (2006.01); C07D 279/20 (2006.01); A61K 9/20 (2006.01); A61L 2/00 (2006.01); A61K 9/28 (2006.01); C07C 309/04 (2006.01); C07C 309/05 (2006.01); C07C 309/30 (2006.01); C07C 309/35 (2006.01); C07C 303/32 (2006.01);
U.S. Cl.
CPC ...
A61K 31/5415 (2013.01); A61K 9/0053 (2013.01); A61K 9/2095 (2013.01); A61L 2/0052 (2013.01); A61P 31/04 (2018.01); A61P 31/12 (2018.01); A61P 31/14 (2018.01); A61P 31/18 (2018.01); A61P 33/02 (2018.01); A61P 33/06 (2018.01); A61P 35/00 (2018.01); C07D 279/20 (2013.01); A61K 9/2893 (2013.01); C07C 303/32 (2013.01); C07C 309/04 (2013.01); C07C 309/05 (2013.01); C07C 309/30 (2013.01); C07C 309/35 (2013.01); Y02A 50/393 (2018.01); Y02A 50/411 (2018.01);
Abstract

Disclosed are compounds of general formula (I): and pharmaceutically acceptable salts thereof, formulations, methods and uses in, for example, the treatment of disease.

Find Patent Forward Citations

Loading…